ReviewToxicological research2025
Chemically-induced histopathological progression in the polycystic ovary syndrome (PCOS)- A review.
Review in Toxicological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine-gynecological disorder, affecting 4-10% of women of reproductive age. Although a fragment of the involved mechanism behind the PCOS occurrence is discovered, the exact etiology and pathophysiology are not completely understood yet. The pathogenesis of the disease involves several genetic, epigenetic, and environmental factors, as well as poor lifestyle. Chemicals that interact adversely with the endocrine glands are ubiquitous in the ecosystem and are known as endocrine-disrupting chemicals. An exposed population, especially women at a growing age, undergoes many hormonal and physiological changes and is more susceptible to developing endocrinological disorders like PCOS. An effective diagnosis of the disease can be made by observing changes in cells that are associated with the progression of the disease. Histopathological changes provide abundant evidence that is directly or indirectly involved in its progression and help in the evaluation of the complexity of the disease. In case of environmental stress, the body responds via some visible changes in cells, including the position and size of small cysts, changes in atretic follicles and ovarian capsules, thickening of ovarian tunica, and increased intra-ovarian cysts are some of the examples that are involved in etiology of disease. Therefore, in this review, we will try to understand the progression of PCOS by observing morphological changes through the histopathology of associated tissues that can be a plausible predictor of malignant changes in the disease. Our primary aim is to summarize the existing literature of experiments and contribute to a better understanding of the disease and associated problems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.